医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2012年
11期
2071-2073
,共3页
心力衰竭,充血性/药物疗法%心钠素/治疗应用
心力衰竭,充血性/藥物療法%心鈉素/治療應用
심력쇠갈,충혈성/약물요법%심납소/치료응용
heart failure ,congestive/DT%atrial natriuretic factor /TU
[目的]评价重组人脑利钠肽(rh‐BNP)对顽固性心衰治疗的近期疗效.[方法]顽固性心衰患者60例,随机分为对照组和观察组,各30例,对照组采用常规抗心衰治疗,观察组在此基础上加用 rh‐BNP 治疗,分别观察两组治疗前、治疗后1 d 、3 d 、7 d 症状并同时检测血清 pro‐BNP ,并记录治疗前和治疗后7 d 左室射血分数( LVEF)、左室舒张末期容积(LVEDV )、左室收缩末期容积(LVESV ).[方法]观察组治疗后心衰症状明显改善( P <0.05),且明显优于对照组( P <0.05);观察组治疗后1 d 、3 d 、7 d 血清 pro‐BNP 逐渐下降( P <0.05),且均明显低于同期对照组( P <0.05);观察组治疗后超声心动图相关指标改善优于同期对照组( P <0.05).[结论]rh‐BNP 治疗顽固性心衰近期效果明显.
[目的]評價重組人腦利鈉肽(rh‐BNP)對頑固性心衰治療的近期療效.[方法]頑固性心衰患者60例,隨機分為對照組和觀察組,各30例,對照組採用常規抗心衰治療,觀察組在此基礎上加用 rh‐BNP 治療,分彆觀察兩組治療前、治療後1 d 、3 d 、7 d 癥狀併同時檢測血清 pro‐BNP ,併記錄治療前和治療後7 d 左室射血分數( LVEF)、左室舒張末期容積(LVEDV )、左室收縮末期容積(LVESV ).[方法]觀察組治療後心衰癥狀明顯改善( P <0.05),且明顯優于對照組( P <0.05);觀察組治療後1 d 、3 d 、7 d 血清 pro‐BNP 逐漸下降( P <0.05),且均明顯低于同期對照組( P <0.05);觀察組治療後超聲心動圖相關指標改善優于同期對照組( P <0.05).[結論]rh‐BNP 治療頑固性心衰近期效果明顯.
[목적]평개중조인뇌리납태(rh‐BNP)대완고성심쇠치료적근기료효.[방법]완고성심쇠환자60례,수궤분위대조조화관찰조,각30례,대조조채용상규항심쇠치료,관찰조재차기출상가용 rh‐BNP 치료,분별관찰량조치료전、치료후1 d 、3 d 、7 d 증상병동시검측혈청 pro‐BNP ,병기록치료전화치료후7 d 좌실사혈분수( LVEF)、좌실서장말기용적(LVEDV )、좌실수축말기용적(LVESV ).[방법]관찰조치료후심쇠증상명현개선( P <0.05),차명현우우대조조( P <0.05);관찰조치료후1 d 、3 d 、7 d 혈청 pro‐BNP 축점하강( P <0.05),차균명현저우동기대조조( P <0.05);관찰조치료후초성심동도상관지표개선우우동기대조조( P <0.05).[결론]rh‐BNP 치료완고성심쇠근기효과명현.
Objective] To evaluate the short‐term efficacy of recombinant human brain natriuretic peptide (RhBNP) for the treatment of intractable heart failure .[Methods]A total of 60 patients with intractable heart failure were randomly divided into control group (n = 30) and observation group(n = 30) .Control group re‐ceived the routine therapy ,while observation group additionally received rhBNP based on routine therapy .The symptoms were observed before and 1 ,3 and 7d after treatment .Meanwhile ,serum pro‐BNP was detected . Left ventricular ejection fraction (LVEF) ,left ventricular end‐diastolic volume (LVEDV ) and left ventricular end‐systolic volume(LVESV) before and 7d after therapy were recorded .[Results]Symptoms of observation group were improved obviously ( P < 0 .05) ,and obviously better than those in control group( P < 0 .05) .Se‐rum pro‐BNP in observation group 1 ,3 and 7d after therapy decreased gradually ( P < 0 .05) ,and was signifi‐cantly lower than that in control group in the corresponding time period ( P < 0 .05) .The improvement of the indexes of ultrasoundcardiogram in observation group was better than that in control group in the correspond ‐ing time period( P < 0 .05) .[Conclusion] The short‐term efficacy of rhBNP for the treatment of intractable heart failure is obvious .